Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Sales | 5,111 | 6,860 | 6,313 | 9,721 | 9,888 |
| Cost of Goods | 5,671 | 4,374 | 3,744 | 6,649 | 6,990 |
| Gross Profit | -560 | 2,485 | 2,569 | 3,072 | 2,898 |
| Operating Expenses | 7,378 | 7,277 | 6,638 | 7,329 | 7,188 |
| Operating Income | -7,267 | -4,417 | -3,325 | -3,608 | -3,300 |
| Interest Expense | 712 | 662 | 651 | 196 | 0 |
| Other Income | 0 | 0 | -13 | 0 | 6 |
| Pre-tax Income | -7,979 | -5,079 | -3,989 | -3,804 | -3,294 |
| Income Tax | -135 | -80 | -100 | -21 | -107 |
| Net Income Continuous | -7,844 | -5,000 | -3,889 | -3,783 | -3,187 |
| Net Income | $-7,844 | $-5,000 | $-3,889 | $-3,783 | $-3,187 |
| EPS Basic Total Ops | -0.42 | -0.29 | -0.24 | -0.22 | -0.19 |
| EPS Basic Continuous Ops | -0.42 | -0.29 | -0.23 | -0.22 | -0.19 |
| EPS Diluted Total Ops | -0.42 | -0.29 | -0.24 | -0.22 | -0.19 |
| EPS Diluted Continuous Ops | -0.42 | -0.29 | -0.23 | -0.22 | -0.19 |
| EBITDA(a) | $-6,559 | $-3,683 | $-3,076 | $-2,691 | $-2,905 |